Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the US and the EU.

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...

On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...

The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds, and auto ...

Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...

England has launched a world-first gonorrhoea vaccination programme that will potentially help avert up to 100,000 cases of the disease and save millions of NHS funding.

HPMA hails Lalit Goel's promotion as state drugs controller- cum-Licensing Authority: Peethaambaran Kunnathoor, Chennai ...

Mumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first ...

The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower ...

Shares of German packaging and medical equipment maker Gerresheimer jumped around 4% in early trading on Tuesday after the ...

Gerresheimer has announced plans to separate its moulded glass business following a comprehensive strategic review aimed at ...